Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Poitiers University Hospital

Status

Completed

Conditions

The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes

Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father

Identification of the Mother or Fetus Contamination by SARS Cov-2

Analysis Laboratories of the Poitiers CHU

Treatments

Diagnostic Test: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus

Study type

Interventional

Funder types

Other

Identifiers

NCT04387253

GYNE-COVID

Details and patient eligibility

About

Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses.

Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies.

If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination.

The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.

Enrollment

28 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Major patient
Patient with late spontaneous abortion (≥15 weeks of gestation)
Benefiting from a Social Security scheme
Patient who consented to participate in the study
Free subject, without tutorship, curatorship or subordination

Exclusion criteria

Persons not benefiting from a Social Security scheme or not benefiting from it through a third party.
Concurrent participation in another clinical research study.